Cargando…
Recent advances in managing gastrointestinal stromal tumor
Constitutive activating mutations in KIT and platelet-derived growth factor receptor α ( PDGFRα) are heavily involved in the pathobiology of gastrointestinal stromal tumors (GISTs). This disease has served as an effective “proof-of-concept” model for targeting gain-of-function kinase mutations in ca...
Autores principales: | Duffaud, Florence, Le Cesne, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600003/ https://www.ncbi.nlm.nih.gov/pubmed/28928967 http://dx.doi.org/10.12688/f1000research.11118.1 |
Ejemplares similares
-
Recent advances in the management of gastrointestinal stromal tumors
por: Duffaud, Florence, et al.
Publicado: (2010) -
Recent advances in the management of gastrointestinal stromal tumor
por: Ahmed, Monjur
Publicado: (2020) -
Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients
por: Duffaud, Florence, et al.
Publicado: (2012) -
Recent advances in understanding and managing leiomyosarcomas
por: Duffaud, Florence, et al.
Publicado: (2015) -
Recent advances and novel agents for gastrointestinal stromal tumor (GIST)
por: Lamba, Gurpreet, et al.
Publicado: (2012)